Search Results

You are looking at 11 - 20 of 2,686 items for :

  • Refine by Access: Content accessible to Me x
Clear All
Full access

CLO19-042: Quality Assurance for Cancer Radiotherapy: An Update on the Ottawa Hospital Peer Review Experience

Shawn Malone, Eduardo Gaviolli, Julia Malone, and Julie Renaud

Background: Peer review is an important quality assurance (QA) tool in cancer care. For radiotherapy (XRT), peer review is challenging because of the complexity of XRT targets and treatment planning and significant patient numbers. During review

Full access

Exocrine Pancreas Cancer and Thromboembolic Events: A Systematic Literature Review

Andrew S. Epstein and Eileen M. O'Reilly

of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www

Full access

Impact of NCI-Mandated Scientific Review on Protocol Development and Content

Ning Ning, Jingsheng Yan, Xian-Jin Xie, and David E. Gerber

objectives becoming obsolete. 1 Researchers have voiced concerns about the complexity, length, inconsistencies, excessive demands, and inappropriate conservatism of the review process. 2 – 6 In turn, these steps contribute to delays in and escalating costs

Full access

Psychostimulants for Cancer-Related Fatigue

William Breitbart and Yesne Alici

relieved fatigue because of chemotherapy-induced anemia. 2 This article is a comprehensive review of psychostimulants, including the traditional psychostimulant medications and the wakefulness-promoting agents used in the management of cancer

Full access

Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials

Rachel A. Bender Ignacio, Lilie L. Lin, Lakshmi Rajdev, and Elizabeth Chiao

, clinical trials for HIV-associated malignancies (HIVAMs) have also tremendously evolved. Until recently, most cancer-specific treatment trials excluded PLWH. For example, the Friends of Cancer Research HIV Working Group reviewed eligibility criteria from

Full access

Merkel Cell Carcinoma: A Review of Current Advances

Frank Qian Zhan, Vathani Sharon Packianathan, and Nathalie Charlotte Zeitouni

blame . J Invest Dermatol 2007 ; 127 : 2100 – 2103 . 5 Ries LG Melbert D Krapcho M . SEER Cancer Statistics Review, 1975–2005 . Available at: http://seer.cancer.gov/faststats/index.php . Accessed January 23, 2009 . 6 Heath M

Full access

Key Performance Indicators and Metrics for the Implementation of an Oral Chemotherapy Adherence Program

Benyam Muluneh, James B. Collins IV, Brian Lam, Emily Mackler, and Jennifer Elston Lafata

target values that indicate improved patient care by an oral chemotherapy adherence program. Methods Members of the study team conducted a narrative review of the literature to compile an initial list of KPIs, metrics of the KPIs, and targets for

Full access

Review of Evidence-Based Support for Pretreatment Imaging in Melanoma

Michael S. Sabel and Sandra L. Wong

Edited by Kerrin G. Robinson

melanoma . Cancer 2005 ; 104 : 570 – 579 . 35 Alvarez S Anorbe E Alcorta P . Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review . AJR Am J Roentgenol 2006 ; 186 : 1342 – 1348

Full access

A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice

Pamala A. Pawloski, Gabriel A. Brooks, Matthew E. Nielsen, and Barbara A. Olson-Bullis

systems in oncology practice, we conducted a systematic review of the literature describing real-world implementation of CDS tools for the diagnosis, treatment, and supportive care of patients with cancer. Our objective was to investigate the reported

Full access

Evaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic Review

Ghadeer Olleik, Wassim Kassouf, Armen Aprikian, Jason Hu, Marie Vanhuyse, Fabio Cury, Stuart Peacock, Elin Bonnevier, Ebba Palenius, and Alice Dragomir

review was to assess the clinical utility of newly marketed tests for use in PCa management before initial or repeat biopsy (after negative biopsy), after positive biopsy, and post-prostatectomy. Methods Literature Search The Cochrane, Embase